Target intelligence / Profile preview

Cellular DNA and other macromolecular structures (DNA)

Target
DNA
Molecular classification
Nucleic acid, Macromolecule, Other
01

Overview

Cellular DNA and other macromolecular structures represent a broad class of non-protein therapeutic targets essential for the storage and expression of genetic information. DNA serves as the primary template for replication and transcription, processes that are fundamental to cell survival and proliferation. In clinical practice, these structures are primarily targeted by cytotoxic chemotherapy agents used to treat various forms of cancer. These drugs, such as alkylating agents and platinum-based compounds, induce structural damage or chemical modifications to the DNA, which halts the cell cycle and induces apoptosis in rapidly dividing cells. While highly effective at reducing tumor burden, the non-specific nature of targeting genomic DNA often results in significant toxicity to healthy, rapidly renewing tissues like bone marrow and the intestinal epithelium. Additionally, long-term exposure to DNA-damaging agents carries a risk of inducing new mutations that may lead to secondary cancers.

Other names
Deoxyribonucleic acidGenomic DNANuclear DNAMacromolecular targetsNucleic acids
02

Mechanism of action

Drugs targeting these structures typically act via covalent DNA cross-linking, alkylation of nucleotide bases, or intercalation between base pairs. These actions physically obstruct the DNA double helix, preventing the progression of DNA polymerase and RNA polymerase. This leads to the inhibition of DNA replication and RNA synthesis, eventually triggering DNA damage response pathways and programmed cell death (apoptosis).

03

Biological functions

Genetic information storageDNA replicationTranscriptionCell divisionDNA repair
04

Disease associations

CancerInfectionGenetic disordersAutoimmune disease
05

Safety considerations

MutagenicitySecondary malignanciesMyelosuppressionTeratogenicityGastrointestinal toxicityAlopecia
06

Interacting drugs

Cisplatin

8 more in the full profile.

07

Biomarkers

Gamma-H2AX (DNA damage marker)Microsatellite instability (MSI)Tumor mutational burden (TMB)BRCA1/2 mutation statusp53 status

Beyond the preview

Go deeper on Cellular DNA and other macromolecular structures (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular DNA and other macromolecular structures (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call